SupplierRadar

Seafood Joint Stock Company No.4 Branch Dong Tam

FDA import alert and refusal historyDong Thap, VietnamFEI 3009819031

Recorded by FDA as SEAFOOD JOINT STOCK COMPANY NO.4 BRANCH DONG TAM

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Seafood Joint Stock Company No.4 Branch Dong Tam.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectSeafood Joint Stock Company No.4 Branch Dong Ta added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Seafood Joint Stock Company No.4 Branch Dong Tam (Dong Thap, Vietnam) is on the red list of FDA Import Alert 16-124 (Aquaculture seafood: unapproved drugs) for frozen swamp eel chunk, published by FDA on December 30, 2016, and has 1 FDA import refusal recorded since October 2016.

Data from FDA public records, last checked . Request a correction

Current status

Last import refusal
Eel · VETDRUGRES
Last warning letter
None found
Last inspection
Classified NAI (No Action Indicated)

Every FDA record for Seafood Joint Stock Company No.4 Branch Dong Tam

3 records, newest first. Each line links to the FDA page it came from.

2016

  1. Import alert listing
    Listed on Import Alert 16-124red listFrozen Swamp Eel Chunk
    Source
  2. Import refusal
    Refused, EelVETDRUGRESEntry AQZ-0406764-4
    Source

2015

  1. Inspection
    Inspection classified NAI (No Action Indicated)Foodborne Biological Hazards
    Source

Refusal charges, in plain English

  • VETDRUGRES1 refused line

    Animal drug residue

    The product appeared to contain a new animal drug, or a conversion product of one, that is unsafe within the meaning of section 512 of the FD&C Act.

Questions about Seafood Joint Stock Company No.4 Branch Dong Tam

Is Seafood Joint Stock Company No.4 Branch Dong Tam on an FDA import alert?
Yes. As of October 26, 2026, Seafood Joint Stock Company No.4 Branch Dong Tam is on the red list of FDA Import Alert 16-124, “Aquaculture seafood: unapproved drugs”, for frozen swamp eel chunk; FDA published the listing on December 30, 2016.
Has FDA refused shipments from Seafood Joint Stock Company No.4 Branch Dong Tam?
Yes. FDA refused 1 shipment line from Seafood Joint Stock Company No.4 Branch Dong Tam on December 23, 2016. The most recent, on December 23, 2016, was eel, charged as VETDRUGRES (animal drug residue).
Why did FDA refuse Seafood Joint Stock Company No.4 Branch Dong Tam's shipments?
The most frequent charge is VETDRUGRES (animal drug residue, 1 line).
When was Seafood Joint Stock Company No.4 Branch Dong Tam last inspected by FDA?
FDA's most recent inspection of Seafood Joint Stock Company No.4 Branch Dong Tam with a final classification is dated June 16, 2015 and was classified NAI (No Action Indicated).
What is Seafood Joint Stock Company No.4 Branch Dong Tam's FEI number?
Seafood Joint Stock Company No.4 Branch Dong Tam's FDA Establishment Identifier (FEI) is 3009819031.
Can shipments from Seafood Joint Stock Company No.4 Branch Dong Tam still enter the U.S.?
Shipments of frozen swamp eel chunk from Seafood Joint Stock Company No.4 Branch Dong Tam can be detained without physical examination under Import Alert 16-124; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).

Buying from Seafood Joint Stock Company No.4 Branch Dong Tam?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Seafood Joint Stock Company No.4 Branch Dong Tam.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectSeafood Joint Stock Company No.4 Branch Dong Ta added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.